LON:SER 5533861 (SER.L) (SER) Share Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About 5533861 (SER.L) Stock (LON:SER) 30 days 90 days 365 days Advanced Chart Remove Ads Get 5533861 (SER.L) alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume60.79 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewSefton Resources, Inc. is a United States-based company, which is engaged in the exploration, development and production of oil and natural gas. The Company is also engaged in gathering and transporting natural gas in the Continental United States. The Company's properties are located in California and Kansas, the United States. It has approximately 40,000 acres in the Forest City Basin of Eastern Kansas to develop Coal Bed Methane gas, as well as conventional oil and gas projects. The Company also owns a transmission pipeline in Kansas. The Company's subsidiaries include TEG MidContinent and TEG Transmission.Read More… Remove Ads Receive SER Stock News and Ratings via Email Sign-up to receive the latest news and ratings for 5533861 (SER.L) and its competitors with MarketBeat's FREE daily newsletter. Email Address SER Stock News HeadlinesSerina Therapeutics Secures $5 Million in Funding to Support Advancement of SER-252 into Clinical Development in Advanced Parkinson's DiseaseApril 8 at 4:30 PM | globenewswire.comSerina Therapeutics to Present at the Jones Healthcare and Technology Innovation ConferenceApril 7 at 6:30 AM | globenewswire.com[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the biggest "dollar reset" since 1971.April 9, 2025 | Colonial Metals (Ad)Serina Therapeutics Reports Full Year 2024 Financial Results and Recent Business HighlightsMarch 24, 2025 | globenewswire.comSerina Therapeutics to Present at the American Chemistry Society (ACS) Spring 2025 MeetingMarch 24, 2025 | globenewswire.comSerina Therapeutics Appoints Dr. Jay Venkatesan to its Board of DirectorsFebruary 12, 2025 | globenewswire.comSerina Therapeutics Receives Second $5 Million Tranche to Strengthen Cash Position Ahead of Phase 1 Clinical Trial in Advanced Parkinson's Disease PatientsFebruary 3, 2025 | globenewswire.comSerina Therapeutics Announces Sale of UniverXome SubsidiaryJanuary 15, 2025 | globenewswire.comSee More Headlines SER Stock Analysis - Frequently Asked Questions How do I buy shares of 5533861 (SER.L)? Shares of SER stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of 5533861 (SER.L) own? Based on aggregate information from My MarketBeat watchlists, some other companies that 5533861 (SER.L) investors own include Serco Group (SRP), Sosandar (SOS), Cadence Minerals (KDNC), Gulf Keystone Petroleum (GKP) and Echo Energy (ECHO). Industry, Sector and Symbol Stock ExchangeLON SectorManufacturing Industry Pharmaceutical Preparations Sub-IndustryPharmaceutical Products Current SymbolLON:SER CIKN/A Webwww.seftonresources.com Phone+44-20-78725570FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report This page (LON:SER) was last updated on 4/9/2025 by MarketBeat.com Staff From Our PartnersTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredElon’s Silver Play? Trump Clears the PathNothing is confirmed—yet. But Musk has disrupted every industry he's touched, and Trump's policies make the ti...Priority Gold | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 5533861 (SER.L) Please log in to your account or sign up in order to add this asset to your watchlist. Share 5533861 (SER.L) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.